254 related articles for article (PubMed ID: 31923535)
1. Laser facilitates week-long sustained transdermal drug delivery at high doses.
Kakar P; Li Z; Li Y; Cao Y; Chen X
J Control Release; 2020 Mar; 319():428-437. PubMed ID: 31923535
[TBL] [Abstract][Full Text] [Related]
2. Sustained epidermal powder drug delivery via skin microchannels.
Cao Y; Kakar P; Hossen MN; Wu MX; Chen X
J Control Release; 2017 Mar; 249():94-102. PubMed ID: 28132934
[TBL] [Abstract][Full Text] [Related]
3. Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug.
Naser YA; Tekko IA; Vora LK; Peng K; Anjani QK; Greer B; Elliott C; McCarthy HO; Donnelly RF
J Control Release; 2023 Apr; 356():416-433. PubMed ID: 36878320
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.
Chen X; Shah D; Kositratna G; Manstein D; Anderson RR; Wu MX
J Control Release; 2012 Apr; 159(1):43-51. PubMed ID: 22261281
[TBL] [Abstract][Full Text] [Related]
5. Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application.
Zhao Y; Voyer J; Li Y; Kang X; Chen X
Expert Opin Drug Deliv; 2023 Jan; 20(1):31-54. PubMed ID: 36519356
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
7. Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin.
Wenande E; Tam J; Bhayana B; Schlosser SK; Ishak E; Farinelli WA; Chlopik A; Hoang MP; Pinkhasov OR; Caravan P; Rox Anderson R; Haedersdal M
J Control Release; 2018 Apr; 275():242-253. PubMed ID: 29454062
[TBL] [Abstract][Full Text] [Related]
8. Smart Responsive Microarray Patches for Transdermal Drug Delivery and Biological Monitoring.
Zhao L; Zhang C; Abu-Ershaid JM; Li M; Li Y; Naser Y; Dai X; Abbate MTA; Donnelly RF
Adv Healthc Mater; 2021 Oct; 10(20):e2100996. PubMed ID: 34449129
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous drug delivery by liposomes using fractional laser technology.
Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
[TBL] [Abstract][Full Text] [Related]
10. Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects.
Zhou B; Liu S; Yin H; Qi M; Hong M; Ren GB
Eur J Pharm Sci; 2021 Sep; 164():105915. PubMed ID: 34146681
[TBL] [Abstract][Full Text] [Related]
11. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
12. Topical delivery of PD-1 inhibitors with laser-assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns.
Christensen RL; Hendel KK; Persson DP; Husted S; Olesen UH; Haedersdal M
Lasers Surg Med; 2022 Jan; 54(1):170-181. PubMed ID: 34859463
[TBL] [Abstract][Full Text] [Related]
13. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
14. Drug crystallization - implications for topical and transdermal delivery.
Hadgraft J; Lane ME
Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
[TBL] [Abstract][Full Text] [Related]
15. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin.
Teodorescu F; Quéniat G; Foulon C; Lecoeur M; Barras A; Boulahneche S; Medjram MS; Hubert T; Abderrahmani A; Boukherroub R; Szunerits S
J Control Release; 2017 Jan; 245():137-146. PubMed ID: 27914995
[TBL] [Abstract][Full Text] [Related]
16. Spray-on transdermal drug delivery systems.
Ibrahim SA
Expert Opin Drug Deliv; 2015 Feb; 12(2):195-205. PubMed ID: 25227233
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a heparin gel for transdermal delivery via laser-generated micropores.
Vora D; Kim Y; Banga AK
Ther Deliv; 2021 Feb; 12(2):133-144. PubMed ID: 33496196
[No Abstract] [Full Text] [Related]
18. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
19. Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine.
Kochhar JS; Lim WX; Zou S; Foo WY; Pan J; Kang L
Mol Pharm; 2013 Nov; 10(11):4272-80. PubMed ID: 24044683
[TBL] [Abstract][Full Text] [Related]
20. Recent Advancement of Medical Patch for Transdermal Drug Delivery.
Wong WF; Ang KP; Sethi G; Looi CY
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
